TGY2IT
REGN icon

Timothy G. Youngquist 2020 Irrevocable Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Timothy G. Youngquist 2020 Irrevocable Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-152
Closed -$117K – 400
2026
Q1 		$117K Buy
+152
New +$116K 0.05% 144

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Timothy G. Youngquist 2020 Irrevocable Trust's REGN Position: Q2 2026 in Review

Timothy G. Youngquist 2020 Irrevocable Trust sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 152 shares — an estimated $117K sold.

Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in REGN in Q1 2026 and held it in 1 quarter. The position peaked at $117K in Q1 2026. 729 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Timothy G. Youngquist 2020 Irrevocable Trust reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust sold 152 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $117K.
  • Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in Regeneron Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust's Regeneron Pharmaceuticals position peaked at $117K in Q1 2026.
  • 729 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Timothy G. Youngquist 2020 Irrevocable Trust's 13F filing for Q2 2026, filed 7 Aug 2026.